All tenders
CF-3414000D0O000000rwimUAA
Oncotype DX Breast Cancer Testing
East Sussex Healthcare NHS Trust · United Kingdom
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- CF-3414000D0O000000rwimUAA
- Issuing organization
- East Sussex Healthcare NHS Trust · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- Oncotype DX Breast Cancer Testing
- Source
- Contracts Finder (UK)
- Source ID
- be83749f-55db-4eb4-b59b-40aa06ac75c4-886769
Details
- Location
- United Kingdom
Description
Oncotype DX is a validated genomic assay recommended by NICE (DG34) for guiding chemotherapy decisions in specific cohorts of early breast cancer. It provides a Recurrence Score that stratifies patients into groups where chemotherapy is beneficial versus where endocrine therapy alone is sufficient. Additional information: This is a call off contract from framework 2023/S 000-028831 based on previous contracts usage.
Dates
- Publication
- 2026/03/03 09:38:35 AM UTC
- Closing date
- 2026/02/04 12:00:00 PM UTC
Estimated value
$273K GBP
Classification
Normalized category
Other